Stay updated on Ivacaftor Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the Ivacaftor Safety and Efficacy Clinical Trial page.

Latest updates to the Ivacaftor Safety and Efficacy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version of the study, now focusing on the investigation of ivacaftor (VX-770) for chronic obstructive pulmonary disease (COPD) with a revised design and location details. Key information about the study's design and the inclusion criteria has been streamlined.SummaryDifference38%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Ivacaftor Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivacaftor Safety and Efficacy Clinical Trial page.